Development and validation of a scoring system to predict vasovagal reaction upon whole-blood donation.

Autor: Hashizume T; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan., Kondo G; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan., Ishimaru F; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan., Ikeda Y; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan., Kagawa K; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan., Kunii N; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan., Namba N; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan., Aoki K; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan., Sawamura Y; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan., Makino S; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.

Publikováno v: Vox sanguinis [Vox Sang] 2024 Apr; Vol. 119 (4), pp. 300-307. Date of Electronic Publication: 2023 Dec 29.

Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation in adults with relapsed/refractory non-Hodgkin lymphoma.

Autor: Nishikubo M; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan. mnishi90@yahoo.co.jp., Shimomura Y; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan., Nakaya Y; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Shinohara A; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan., Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan., Takayama N; Department of Hematology, Kyorin University Faculty of Medicine, Mitaka-shi, Japan., Kobayashi H; Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan., Uehara Y; Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kitakyushu, Japan., Ishikawa J; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan., Ishiwata K; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Kajigaya, Japan., Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan., Nakazawa H; Department of Hematology and Medical Oncology, Shinshu University School of Medicine, Nagano, Japan., Kataoka K; Division of Hematology, Department of Medicine, Keio University School of Medicine, Keio, Japan., Kanda J; Department of Hematology, Kyoto University Hospital, Kyoto, Japan., Nagafuji K; Division of Hematology and Oncology, Department of Medicine, Kurume University Hospital, Kurume, Fukuoka, Japan., Kozai Y; Department of Hematology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan., Matsuhashi Y; Department of Hematology, Kawasaki Medical School, Kurashiki, Japan., Ishimaru F; Technical Department, Japanese Red Cross Society Blood Service Headquarters, Tokyo, Japan., Kim SW; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Kanda Y; Division of Hematology, Jichi Medical University, Shimotsuke, Tochigi, Japan., Atsuta Y; Japanese Data Center For Hematopoietic Cell Transplantation, Tokyo, Japan.; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Tokyo, Japan., Kondo E; Department of Hematology, Kawasaki Medical School, Kurashiki, Japan., Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2024 Dec; Vol. 59 (12), pp. 1735-1743. Date of Electronic Publication: 2024 Sep 25.

Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remission.

Autor: Shimomura Y; Department of Hematology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe, Japan; Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Suita, Japan. Electronic address: shimomura_0119@yahoo.co.jp., Kitamura T; Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Suita, Japan., Yanada M; Department of Hematology and Oncology, Nagoya City University East Medical Center, Nagoya, Japan., Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan., Kondo T; Department of Hematology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe, Japan., Yoshihara S; Department of Hematology, Hyogo Medical University Hospital, Hyogo, Japan., Tanaka M; Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan., Inai K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Katayama Y; Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan., Onizuka M; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan., Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Nakamae H; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Kurokawa M; Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Japan., Yano S; Clinical oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan., Nara M; Division of Hematology, Nephrology and Rheumatology, Akita University Hospital, Akita, Japan., Masuko M; Department of Hematopoietic Cell Therapy, Department of Hematology, Niigata University Medical and Dental Hospital, Niigata, Japan., Miyakoshi S; Department of Hematology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan., Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan., Yoshimitsu M; Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Ishimaru F; Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Kanagawa, Japan., Kanda J; Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan., Konuma T; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Publikováno v: Cytotherapy [Cytotherapy] 2024 Nov 17. Date of Electronic Publication: 2024 Nov 17.

Superiority of BM over PBSC for recipients with pre-transplant lung dysfunction in HLA-matched allogeneic HCT.

Autor: Kawamura S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Emerging Medicine for Integrated Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan., Tamaki M; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Emerging Medicine for Integrated Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan., Konuma T; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Onizuka M; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan., Sakaida E; Department of Hematology, Chiba University Hospital, Chiba, Japan., Hayashi H; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Nishida T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan., Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan., Ohigashi H; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan., Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Ishikawa J; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan., Matsuoka KI; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan., Kawakita T; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan., Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan., Ishimaru F; Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan., Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan., Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Hematology, Jichi Medical University, Shimotsuke, Japan., Yakushijin K; Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan., Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Nakasone H; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Emerging Medicine for Integrated Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan. Electronic address: nakasone-tky@umin.ac.jp.

Publikováno v: Cytotherapy [Cytotherapy] 2024 Nov; Vol. 26 (11), pp. 1353-1361. Date of Electronic Publication: 2024 Jun 12.

Comparison of haploidentical transplantation and single cord blood transplantation for myelofibrosis.

Autor: Sakatoku K; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. k.sakatoku@omu.ac.jp., Murata M; Department of Hematology, Shiga University of Medical Science, Otsu, Japan., Shimazu Y; Department of Hematology, Kyoto University Hospital, Kyoto, Japan., Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan., Yoshihara S; Department of Hematology, Hyogo College of Medicine Hospital, Nishinomiya, Japan., Uehara Y; Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kitakyushu, Japan., Takahashi S; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Kobayashi H; Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan., Tanaka H; Department of Hematology, Nara Medical University Hospital, Nara, Japan., Nakano N; Department of Hematology, Imamura General Hospital, Kagoshima, Japan., Ishimaru F; Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan., Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan., Nagamura-Inoue T; Department of Cell Processing and Transfusion, Department of Hematology/Oncology, Institute of Medical Science, the University of Tokyo, Tokyo, Japan., Nakamae H; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2024 May; Vol. 59 (5), pp. 705-707. Date of Electronic Publication: 2024 Feb 20.